Early sexual intercourse and human papillomavirus as risk factors of cervical intraepithelial neoplasia

Introduction: Cervical intraepithelial neoplasia (CIN) is a premalignant lesion that is diagnosed by histology as CIN1, CIN2, or CIN3. Cervical intraepithelial neoplasia results from HPV infection within cervical cells[1]. An earlier age at first sexual intercourse (AFSI) is associated with an elevated risk of HPV acquisition due to cervical cellular immaturity and a reduced capacity to clear persistent infections. HPV infections are mainly transmitted through sexual contact and thus all women who are sexually active are at risk of cervical cancer[2]. Among these factors, the relative contributions and impacts of AFSI and HPV infection have attracted significant interest but remain insufficiently investigated. Purpose of the Study: Investigate the association between AFSI and HPV infection as independent and synergistic risk factors for CIN. By assessing various ages at which women experience their first sexual intercourse, this study seeks to evaluate the impact of these ages on the susceptibility to acquiring CIN. Methods and Materials: This correlational study, which utilized a structured questionnaire and a review of theoretical frameworks, was conducted among women of different age groups, specifically those aged 20-30 years old. The study population was restricted to women without a cervical cancer history. Additionally, data were extracted from 8 related scientific journals for comprehensive multivariate analysis. Research Result: This study analyzed 186 women with histologically confirmed CIN. The results demonstrated a significant inverse relationship between AFSI and CIN prevalence. The women with AFSI ≥21 years (n=34, 16,28%) with odds ratio (OR) was (OR: 1.80), while those with AFSI 17-20 years (n=71, 38,17%) showed elevated risk (OR: 2.44), and the youngest debut group AFSI ≤16 years, (n=81, 43,55%) exhibited the highest risk (OR: 4.09). Additionally, the HPV prevalence analysis revealed 17 cases among women with AFSI ≥21 years (OR: 1.00), 36 cases in the AFSI 17-20 years group (OR: 2.10), and 42 cases in the AFSI ≤16 years (OR: 2.48). Questionnaire-derived data from 47 participants showed significant (p